Category: Company
Quick infos Trade prices Volume: Market Cap: 499.17M Prev closed: Open: 12 High: 12.16 Low: 11.84 52 week low: 11.83 52 week high: 34.71 Dividends: No Dividends Next ER: November 16, 2021
About the Company Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.
Earnings History Date EPS / Forecast Revenue / Forecast March 14, 2022 November 16, 2021 - / -0.6629- / 15.62MNovember 4, 2021 -0.82 / -0.82348.31M / 11.14MAugust 5, 2021 -0.88 / -0.730114.62M / 11.1MBeat! May 6, 2021 -0.28 / -0.816727.97M / 7.81MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Dec 1, 2021 9.19 9.18 9.33
9.14
48.60K 6.61% Nov 30, 2021 8.62 8.75 8.99
8.15
348.67K 2.99% Nov 29, 2021 8.37 8.89 9.08
8.30
148.18K -3.68% Nov 26, 2021 8.69 8.58 8.78
8.53
81.71K -0.34% Nov 24, 2021 8.72 8.47 8.81
8.30
118.07K 4.56% Nov 23, 2021 8.34 8.48 8.51
8.17
240.22K -0.24% Nov 22, 2021 8.36 8.82 8.82
8.35
344.16K -6.17% Nov 19, 2021 8.91 9.08 9.10
8.80
204.34K -2.09% Nov 18, 2021 9.10 9.45 9.47
8.96
178.05K -3.6% Nov 17, 2021 9.44 9.69 9.81
9.16
214.90K -3.28% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1999 Employees:122 News
Cellectis Announces Release of Abstracts at ASH Showcasing Updated Preliminary Clinical Data from BALLI-01 Study and First Preclinical Data from TALGlobin01 finance.yahoo.com Jan 6, 2022 9:13 am
Cellectis Provides Business Objectives for 2022 and Updates its Corporate Presentation finance.yahoo.com Jan 4, 2022 4:30 pm
Monthly information on share capital and company voting rights finance.yahoo.com Dec 6, 2021 4:30 pm
Cytovia, Cellectis Expand Collaboration On Gene-Edited Cancer Platform In China finance.yahoo.com Nov 19, 2021 7:09 am
Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Product Candidate Targeting Mesothelin to Treat Solid Tumors at the Annual Meeting of the Society for Immunotherapy of Cancer finance.yahoo.com Nov 12, 2021 8:09 am
Cellectis SA (CLLS) Q3 2021 Earnings Call Transcript fool.com Nov 5, 2021 5:00 pm
Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du deuxième trimestre 2021 le vendredi 6 août à 14h00 CET finance.yahoo.com Oct 8, 2021 4:34 pm MNTV, AUTL, ALLO and CLLS among after hours movers seekingalpha.com Oct 8, 2021 5:49 am
Monthly information on share capital and company voting rights finance.yahoo.com Sep 10, 2021 4:30 pm CLLS is at high risk of performing badly seekingalpha.com Aug 17, 2021 9:32 pm Cellectis SA (CLLS) Q2 2021 Earnings Call Transcript fool.com Aug 6, 2021 7:00 pm Cellectis EPS misses by $0.28, beats on revenue seekingalpha.com Aug 6, 2021 4:33 am
Monthly information on share capital and company voting rights finance.yahoo.com Aug 2, 2021 4:30 pm
Cellectis Unveils Four Additional Preclinical Candidates For Solid Tumors finance.yahoo.com Jun 15, 2021 7:23 am
10 Best Cheap Tech Stocks to Buy According to Cathie Wood finance.yahoo.com May 26, 2021 10:53 am
Monthly information on share capital and company voting rights finance.yahoo.com May 10, 2021 4:30 pm
Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021 finance.yahoo.com Oct 19, 2021 4:30 pm
Monthly information on share capital and company voting rights finance.yahoo.com Oct 11, 2021 4:30 pm
Cellectis Announces Participation in Five Investor Conferences finance.yahoo.com Aug 26, 2021 4:34 pm
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021 finance.yahoo.com Aug 5, 2021 4:30 pm This company doesn't provide a dividend.
Key Persons CEO : André Choulika, PhD Talk about Cellectis SA below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?
